Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Christopher Cabell > Profile

Christopher Cabell

Affiliations

  • President & Head Of R&D at Inhibikase Therapeutics Inc. (IKT), 2025-07-03
  • Cmo & Head Of R&D at Zura Bio Ltd (ZURA), 2023-05-23
  • Director at Pulmatrix Inc. (PULM), 2023-01-30
  • Evp, Head Of R&D, And Cmo at Arena Pharmaceuticals Inc (ARNA), 2020-11-30
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ARNA $68.00 13,000 $884,000.00 0 2020-07-15 Filing